Stefan Eßer
Biographic Data
| ID | 7747955 |
|---|---|
| NAME | Stefan Eßer |
| GIVEN NAMES | Stefan |
| FAMILY NAME | Eßer |
| SIGNATURE | ESSER S |
| AFFILIATIONS | Essen University Hospital |
| ORCID | 0000-0002-3625-9650 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
HPV knowledge and acceptance of HPV vaccination among men who have sex with men (MSM) in Germany
Despite almost 80% participants being aware of HPV, vaccination uptake was low among all participants. More information about HPV, i.e., through physicians and social networks, might support informed decision-making. Further, facilitating access by offering reimbursement options for vaccination could potentially be a factor to help increase HPV vaccination uptake among MSM in Germany
HIV pre-exposure prophylaxis (PrEP)
Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretro…
This 96-week, randomized, open-label study was designed to assess the efficacy and safety of two single-tablet regimens in treatment naïve HIV-1-infected adults: rilpivirine (RPV) + emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) and efavirenz (EFV) + FTC/TDF. Assessments included patient-reported Medication Adherence Self-Report Inventory, SF-12v2 Quality of Life assessment, HIV Treatment Satisfaction Questionnaire, and HIV Symptom Index Q…
From pills to patients
A substantial increase in the number of people receiving ART was observed from 2006 to 2013 in Germany
No prominent works on this page.
From pills to patients
A substantial increase in the number of people receiving ART was observed from 2006 to 2013 in Germany
HIV pre-exposure prophylaxis (PrEP)
Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretro…
This 96-week, randomized, open-label study was designed to assess the efficacy and safety of two single-tablet regimens in treatment naïve HIV-1-infected adults: rilpivirine (RPV) + emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) and efavirenz (EFV) + FTC/TDF. Assessments included patient-reported Medication Adherence Self-Report Inventory, SF-12v2 Quality of Life assessment, HIV Treatment Satisfaction Questionnaire, and HIV Symptom Index Q…
HPV knowledge and acceptance of HPV vaccination among men who have sex with men (MSM) in Germany
Despite almost 80% participants being aware of HPV, vaccination uptake was low among all participants. More information about HPV, i.e., through physicians and social networks, might support informed decision-making. Further, facilitating access by offering reimbursement options for vaccination could potentially be a factor to help increase HPV vaccination uptake among MSM in Germany
HIV/AIDS Research and Interventions (3 works) · Medicine (3 works) · Antiretroviral therapy (2 works) · Biostatistics (2 works) · Emtricitabine (2 works) · Epidemiology (2 works) · HIV Research and Treatment (2 works) · HIV/AIDS drug development and treatment (2 works) · Internal Medicine (2 works) · Men who have sex with men (2 works)